Clinical Trials Directory

Trials / Suspended

SuspendedNCT01244256

Efficacy and Comparative of the Association Beclomethasone Clotrimzaol + Gentamicin in Patients With Acne Contaminated

Isolation and Comparative Efficacy of the Combination of beclometasona0, 025% + Gentamicin 0.1% + Clotrimazole 1% Topical Dermatological Cream of GLENMARK PHARMACEUTICALS, in Patients Infected With Acne

Status
Suspended
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Azidus Brasil · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The objective of this trial is to evaluate the comparative efficacy of the combination of Clotrimazole + Gentamicin + Beclomethasone in study subjects with a condition of contaminated dermatosis showing bilateral symmetrical lesions.

Detailed description

The specific objective is to evaluate, by means of analytical propedeutics medical improvement in clinical signs and symptoms related to acne infected, the use of the association: Clotrimazole, Gentamicin and Beclomethasone versus association: Clotrimazole and Gentamicin, which will first be randomized. The study should be conducted with 20 research subjects aged over 18 years, of both sexes, showing the framework of bilateral lesions infected with acne, at any stage of evolution. The study subjects will receive treatment with both products, so they can use one in each lesion chosen at random, double-blind. Thus, the proven efficacy and safety and taking all possible adverse events reported, the study sponsor hopes to obtain registration with the Ministry of Health of this new association in the country. The association made a proposal was developed by the Laboratory Glenmark Pharmaceuticals Ltd..

Conditions

Interventions

TypeNameDescription
DRUGClotrimazole + Gentamicin + BeclomethasoneTreatment with Clotrimazole + Gentamicin + Beclomethasone
DRUGClotrimazole + GentamicinTreatment with Clotrimazole + Gentamicin

Timeline

Start date
2007-04-01
Primary completion
2007-08-01
Completion
2007-09-01
First posted
2010-11-19
Last updated
2022-11-03

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01244256. Inclusion in this directory is not an endorsement.